Valiant Laboratories

Valiant Laboratories Rule of 40

The Rule of 40 of Valiant Laboratories (VALIANTLAB.NS) as of Nov 4, 2026 is 72.19 %. In the previous year, Rule of 40 was -10.91 % — a change of -761.84% (higher).

Rule of 40

72.19 %

YoY

-761.84%

Last updated:

Rule of 40 of Valiant Laboratories is 2026 72.19 % . Rule of 40 of Valiant Laboratories was 2025 -10.91 % . It decreases by -761.84% higher compared to the previous year.

The Valiant Laboratories Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2022
73.58 INR
Jan 1, 2023
24.82 INR
Jan 1, 2024
-41.49 INR
Jan 1, 2025
-10.91 INR
Jan 1, 2026
72.19 INR
The Valiant Laboratories Rule of 40 history
YEARRule of 40YoY
72.19 %-761.84%
-10.91 %-73.71%
-41.49 %-267.18%
24.82 %-66.27%
73.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Laboratories Stock analysis

What does Valiant Laboratories do? Valiant Laboratories Ltd manufactures paracetamol API/bulk drug for pharmaceutical applications, targeting medical conditions such as headache, muscle ache, arthritis, back ache, toothache, cold, and fever. The company operates a single manufacturing facility at Tarapur industrial estate, approximately 150 km from Nhava Sheva Port (JNPT), producing specialty chemicals and pharma intermediates for domestic and international markets. Its subsidiary, VALIANT ADVANCED SCIENCES PRIVATE LIMITED, supports the company's operations in the pharmaceutical sector. The firm's primary revenue comes from selling paracetamol API and specialty chemicals to pharmaceutical companies and distributors globally. Manufacturing focuses on high-demand applications like pain relief and fever treatment, with products distributed across India and abroad. The company leverages its Tarapur facility's proximity to Nhava Sheva Port for efficient export logistics. Valiant Laboratories Ltd serves the pharmaceutical industry by supplying essential active ingredients, particularly paracetamol, which is widely used in over-the-counter medications. The company's manufacturing capabilities for specialty chemicals and pharma intermediates cater to both domestic and international clients seeking reliable API sources. Its single-location production model ensures focused resource allocation for consistent output quality. Valiant Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Laboratories stock

Rule of 40 of Valiant Laboratories is 72.19 % in 2026.

On Eulerpool you can find the complete historical development of Rule of 40 Valiant Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Valiant Laboratories

All Key Metrics — Valiant Laboratories